Lantheus Holdings, Inc. Stock price
Equities
LNTH
US5165441032
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
61.96 USD | +2.47% | +5.52% | -0.06% |
Financials (USD)
Sales 2024 * | 1.43B | Sales 2025 * | 1.52B | Capitalization | 4.14B |
---|---|---|---|---|---|
Net income 2024 * | 330M | Net income 2025 * | 434M | EV / Sales 2024 * | 2.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.72 x |
P/E ratio 2024 * |
13.1
x | P/E ratio 2025 * |
10.2
x | Employees | 834 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.6% |
Latest transcript on Lantheus Holdings, Inc.
1 day | +2.91% | ||
1 week | +2.16% | ||
Current month | -7.53% | ||
1 month | -11.43% | ||
3 months | -1.71% | ||
6 months | -8.25% | ||
Current year | -2.48% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Markison
CEO | Chief Executive Officer | 64 | 12-08-31 |
Paul Blanchfield
PSD | President | 43 | 20-01-26 |
Robert Marshall
DFI | Director of Finance/CFO | 57 | 18-09-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Markison
CEO | Chief Executive Officer | 64 | 12-08-31 |
James H. Thrall
BRD | Director/Board Member | 80 | 18-01-31 |
Sam Leno
BRD | Director/Board Member | 78 | 12-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.58% | 17 M€ | -0.46% | ||
1.30% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 61.98 | +2.51% | 234 857 |
24-03-27 | 60.46 | +2.91% | 687,854 |
24-03-26 | 58.75 | -0.47% | 1,158,819 |
24-03-25 | 59.03 | +0.02% | 1,011,799 |
24-03-22 | 59.02 | +0.51% | 840,952 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.48% | 4.14B | |
+0.45% | 12.93B | |
-4.69% | 8.1B | |
-5.53% | 5.13B | |
+2.96% | 4.72B | |
-34.08% | 4.4B | |
+15.50% | 2.82B | |
+2.57% | 2.55B | |
+11.81% | 1.92B | |
-1.77% | 1.65B |